Shani BioTechnologies

Solving Racial Bias in Medical Sensing

Current clinical data indicate that Black patients are nearly three times more likely than white patients to experience "occult hypoxemia"—a condition where pulse oximeters overestimate blood oxygen levels. Shani BioTechnologies is directly addressing this disparity. Recently published in BMJ Innovations and Chest Journal, their pioneering technology integrates green light and skin melanin quantification to ensure non-invasive hemoglobin and oxygen measurements are accurate for all skin tones, moving the industry toward a more equitable standard of care.

Read the research in BMJ.
Explore the Chest Journal Publication.